Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers.
BACKGROUND
Acute doses of Ginkgo biloba have been shown to improve attention and memory in young, healthy participants, but there has been a lack of investigation into possible effects on executive function. In addition, only one study has investigated the effects of chronic treatment in young volunteers.


OBJECTIVE
This study was conducted to compare the effects of ginkgo after acute and chronic treatment on tests of attention, memory and executive function in healthy university students.


METHODS
Using a placebo-controlled double-blind design, in experiment 1, 52 students were randomly allocated to receive a single dose of ginkgo (120 mg, n=26) or placebo (n=26), and were tested 4 h later. In experiment 2, 40 students were randomly allocated to receive ginkgo (120 mg/day; n=20) or placebo (n=20) for a 6-week period and were tested at baseline and after 6 weeks of treatment. In both experiments, participants underwent tests of sustained attention, episodic and working memory, mental flexibility and planning, and completed mood rating scales.


RESULTS
The acute dose of ginkgo significantly improved performance on the sustained-attention task and pattern-recognition memory task; however, there were no effects on working memory, planning, mental flexibility or mood. After 6 weeks of treatment, there were no significant effects of ginkgo on mood or any of the cognitive tests.


CONCLUSIONS
In line with the literature, after acute administration ginkgo improved performance in tests of attention and memory. However, there were no effects after 6 weeks, suggesting that tolerance develops to the effects in young, healthy participants.
Elsabagh
Sarah
S
Psychopharmacology Research Unit, Centre for Neuroscience, Hodgkin Building, King's College London, Guy's Campus, London, SE1 1UL, UK. sarah.elsabagh@kcl.ac.uk
Hartley
David E
DE
Ali
Osama
O
Williamson
Elizabeth M
EM
File
Sandra E
SE
D000293:Adolescent; D000328:Adult; D000339:Affect / Q000187:drug effects; D001288:Attention / Q000187:drug effects; D003071:Cognition / Q000187:drug effects*; D005260:Female; D020441:Ginkgo biloba; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D008570:Memory, Short-Term / Q000187:drug effects; D009483:Neuropsychological Tests; D010364:Pattern Recognition, Visual / Q000187:drug effects; D010936:Plant Extracts / Q000494:pharmacology; D011569:Psychiatric Status Rating Scales; D011597:Psychomotor Performance / Q000187:drug effects; D011932:Reading; D013028:Space Perception / Q000187:drug effects; D013997:Time Factors
D010936:Plant Extracts
Life Sci. 2000 Oct 20;67(22):2673-83
11105983
Planta Med. 1995 Apr;61(2):126-9
7753918
Neuropsychologia. 1990;28(10):1021-34
2267054
Int J Neuropsychopharmacol. 2001 Jun;4(2):131-4
11466162
Neuropsychologia. 1991;29(10):993-1006
1762678
Int J Clin Pharmacol Res. 1984;4(2):89-93
6469442
JAMA. 1997 Oct 22-29;278(16):1327-32
9343463
Pharmacol Res Commun. 1985 Nov;17(11):1063-72
3003764
J Cogn Neurosci. 2000 Jan;12(1):142-62
10769312
Cochrane Database Syst Rev. 2002;(4):CD003120
12519586
Pharmacopsychiatry. 1996 Mar;29(2):47-56
8741021
J Int Neuropsychol Soc. 1998 Sep;4(5):474-90
9745237
J Exp Psychol Hum Learn. 1980 Mar;6(2):174-215
7373248
Eur J Neurosci. 2000 Jun;12 (6):1882-90
10886329
J Pharmacol Exp Ther. 2000 Jun;293(3):982-8
10869401
J Neurosci. 1999 May 15;19(10):4011-22
10234030
Eur J Neurosci. 1996 Feb;8(2):353-64
8714706
Free Radic Biol Med. 1998 Jan 15;24(2):298-304
9433905
Pharmacol Biochem Behav. 2003 Jun;75(3):711-20
12895689
J Altern Complement Med. 2000 Jun;6(3):219-29
10890330
Eur J Pharmacol. 2003 Mar 7;464(1):1-8
12600688
Phytomedicine. 2001 Sep;8(5):401-9
11695885
Physiol Behav. 2001 Jul;73(4):659-65
11495672
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
6880820
Arzneimittelforschung. 1985;35(9):1459-65
3910053
Phytother Res. 1999 Aug;13(5):408-15
10441781
Hum Psychopharmacol. 2002 Aug;17 (6):267-77
12404671
Psychopharmacology (Berl). 2004 Apr;172(4):430-4
14647971
Phytother Res. 2001 Aug;15(5):449-51
11507743
Hum Psychopharmacol. 2002 Jan;17(1):35-44
12404705
Pharmacol Biochem Behav. 2003 Jun;75(3):701-9
12895688
Life Sci. 1986 Dec 15;39(24):2327-34
3796196
Arch Neurol. 1998 Nov;55(11):1409-15
9823823
Hum Psychopharmacol. 2002 Jan;17(1):45-9
12404706
JAMA. 2002 Aug 21;288(7):835-40
12186600
Brain Res. 1996 Mar 18;712(2):349-52
8814913
Neuropsychologia. 1995 Jan;33(1):1-24
7731533
J Psychopharmacol. 2005 Mar;19(2):173-81
15728439
Psychopharmacology (Berl). 1989;97(1):17-22
2496420
Arch Med Res. 2003 Sep-Oct;34(5):373-81
14602503
Hum Psychopharmacol. 2004 Mar;19(2):81-90
14994317
Am J Ther. 1996 Jan;3(1):63-73
11856998
Psychopharmacology (Berl). 2000 Sep;151(4):416-23
11026748
Physiol Behav. 2002 Apr 15;75(5):739-51
12020739
J Psychopharmacol. 1993 Jan;7(4):305-15
22290993